BEIJING, Aug. 4 (Xinhua) -- China's Ministry of Health has banned a kind of injection medicine usually used to treat tonsillitis and bronchitis as patients in several provinces and autonomous regions were reported in serious conditions after taking the medicine.

    The antibacterial medicine was manufactured by the Anhui Huayuan Biological Pharmaceutical Co. Ltd. affiliated to the Shanghai Worldbest Co. Ltd., and its chemical name is clindamycin phosphate and glucose injection.

    Patients in Qinghai, Zhejiang, Heilongjiang and Shandong provinces and Guangxi Zhuang Autonomous Region appeared syndromes such as decompensation, naupathia, diarrhea and loss of consciousness after dosing the medicine.

    The Ministry of Health has demanded medical institutions at various levels to immediately stop using and purchasing the medicine made by the company since June.

    The patients are now under observation in local hospitals and their conditions are being recorded and reported. The medicine has been taken sample for test and those already been sold are urgently recalled by local medical authorities. Enditem